Navigation Links
Lumetra Announces Sale of Subsidiary IntegriGuard
Date:9/30/2009

Sale Allows Healthcare Consulting Organization to Focus on Core Business

SAN FRANCISCO, Sept. 30 /PRNewswire/ -- Lumetra, the San Francisco-based healthcare solutions consulting organization, announced today the completion of the sale of its IntegriGuard subsidiary to HMS (Nasdaq: HMSY), a publicly traded company.

In making the announcement, Linda M. Sawyer, Ph.D., RN, Lumetra's Chief Executive Officer, stated: "The sale of IntegriGuard is a significant milestone in the implementation of our strategic plan and allows Lumetra to focus on our core business and clients, driving the advancement of healthcare through evidence-based solutions and technology."

IntegriGuard was formed in 1999 as a national division of Lumetra focusing on the prevention and detection of fraud and abuse in healthcare systems. It was established as a wholly-owned subsidiary in April 2003. The sale is effective immediately.

About Lumetra

Lumetra provides reliable professional services and sustainable solutions through integrated clinical, technological, and analytic expertise to transform the delivery and administration of healthcare. For more information, please visit www.lumetra.com.

SOURCE Lumetra


'/>"/>
SOURCE Lumetra
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Lumetra Program Improves Diabetes Care Among Latinos
2. UCSF Announces Expanded BreastCancerTrials.org Website
3. DSS Research Announces Senior Health Risk Assessment (SrHRA)(TM)
4. US Farms, Inc. Announces Distribution Partnership With Natures Best
5. Datafarm™ Announces HollisterStier Contract Manufacturing Regulatory Affairs Deploys S-Cubed eCTD
6. Hutchinson Metro Center Announces Over 50,000 SF in New Leases for Medical Space at Bronx Complex
7. President Announces Free Health Plan
8. NovoCure Ltd. announces closing of financing round
9. RCRC Independent Review Board Announces DHHS Research Oversight
10. change:healthcare Announces Twitter Application that brings Healthcare Information and Costs to Consumers' Fingertips
11. QRxPharma Announces Strategic Alliance with Liaoning Nuokang Medicines Co Ltd for the Development of Venomics Assets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... , ... April 28, 2017 , ... ... announce the integration of Microsoft(R) Word(TM) Online(TM), which enables sleep physicians to create ... it streamlines the reporting process and provides a familiar interface that does not ...
(Date:4/28/2017)... ... ... sleep affects much more than energy – it also has mental and physical benefits. According ... reaction time, which can increase the risk of having a car accident. , This ... NSF to help you sleep better and feel better:, , Turn ...
(Date:4/28/2017)... ... April 28, 2017 , ... Ushio America proudly ... offer an instant energy-saving solution for F32T8 fluorescent lamps on most instant-start and ... These 50,000 hour rated lamps utilize the existing electronic ballast, saving labor and ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... exposed to more adverse experiences than children in the general population. That’s because ... abuse, neglect or other family challenges. While no fault of their own, youth ...
(Date:4/28/2017)... ... April 28, 2017 , ... Early detection ... improve drug safety and minimize the cost of development. In this webinar, sponsored ... using cell lines and for cardiac toxicity using induced pluripotent stem cells (iPSCs). ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 20, 2017  RXi Pharmaceuticals Corporation (NASDAQ: RXII), ... address significant unmet medical needs, today announced that ... consumer product development program, based on its proprietary ... Investigative Dermatology (SID) 76 th Annual Meeting.  ... the sciences relevant to skin health and disease ...
(Date:4/20/2017)... 20, 2017   ZappRx, Inc ., a digital health ... process, today announced it closed $25 million in Series B ... firm based in Seattle that is ... . The Series B round included participation from SR ... and GV (formerly Google Ventures). As part of ...
(Date:4/20/2017)... -- Eyevensys, a private biotechnology company developing ... technology that enables the safe, local, sustained production of ... range of ophthalmic diseases, announces it has received approval ... (MHRA) to advance its technology into clinical development. ... The EyeCET platform ...
Breaking Medicine Technology: